Based on both previous studies and our own findings, we hypothesize that, in tumor types where ASF1B expression is positively correlated with TMB, high ASF1B expression, and high expression of TMB and MSI predict better prognosis and response to ICI treatment. Here, ASF1B is linked to neoplasm.